Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ovarian testosterone secretion during perimenopause

S L Ala-Fossi1, J Mäenpää, R Aine

  • 1Department of Obstetrics, Tampere University Hospital, Finland. sa12869@uta.fi

Maturitas
|August 12, 1998
PubMed
Summary

Ovarian testosterone secretion increases during the menopausal transition, with the highest levels observed in postmenopausal women. This increased ovarian vein testosterone is not reflected in peripheral blood levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

NSGO-OV-UMB1/ENGOT-OV30: A phase II study of durvalumab in combination with the anti-CD73 monoclonal antibody Oleclumab in patients with relapsed ovarian cancer.

Gynecologic oncology·2024
Same author

Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.

British journal of cancer·2023
Same author

Expression Analysis of Platinum Sensitive and Resistant Epithelial Ovarian Cancer Patient Samples Reveals New Candidates for Targeted Therapies.

Translational oncology·2018
Same author

Compression of the femoral nerve due to endometriosis of the inguinal region.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2018

Area of Science:

  • Reproductive Endocrinology
  • Gynecologic Oncology

Background:

  • Ovarian testosterone production is crucial for female physiology.
  • Understanding changes in ovarian hormone secretion during menopause is vital for women's health.

Purpose of the Study:

  • To investigate ovarian testosterone secretion in pre-, peri-, and postmenopausal women.
  • To correlate testosterone levels with age and ovarian stromal hyperplasia.

Main Methods:

  • Analysis of ovarian and peripheral venous testosterone levels in 52 women (aged 42-69).
  • Categorization of women into premenopausal, perimenopausal, and postmenopausal groups.
  • Measurement of estradiol, progesterone, gonadotropins, and assessment of ovarian stromal hyperplasia.

Main Results:

Related Experiment Videos

  • Ovarian vein steroid hormone levels were higher than peripheral levels.
  • A positive correlation was found between age and ovarian vein testosterone.
  • Increased testosterone secretion was significantly associated with ovarian stromal hyperplasia.

Conclusions:

  • The ovary appears to increase testosterone secretion during the menopausal transition.
  • Postmenopausal women exhibited the highest ovarian vein testosterone levels.
  • Elevated ovarian testosterone was not detected in peripheral circulation.